Questioning Witnesses’ Memories in COPA Trial: Craig Wright’s Perspective The reliability of witness testimony is a crucial aspect of any...
Neurona Therapeutics, a biotechnology company focused on developing cell therapies for neurological disorders, has recently announced securing $120 million in...
Phase IIb trial results have recently revealed that Tozorakimab, a potential treatment for diabetic kidney disease (DKD), did not meet...
In today’s fast-paced business landscape, companies are constantly seeking innovative ways to grow and expand their customer base. Two popular...
Understanding the Site Perspective on eCOA Flexibility in Clinical Trials Electronic Clinical Outcome Assessments (eCOA) have become increasingly popular in...
Orexa Commences Phase 2 Trial in Post-Operative Patients with First Patient Dosed – Drugs.com MedNews Orexa Pharmaceuticals, a leading biopharmaceutical...
An Informative Overview of 15 Different Aspects of Change in Clinical Trial Start-Up and Execution Clinical trials play a crucial...
Montenegro Appellate Court Halts Extradition of Do Kwon In a recent development, the Montenegro Appellate Court has halted the extradition...
The SaaS (Software as a Service) industry has experienced tremendous growth in recent years, with businesses increasingly relying on cloud-based...
Phase I Thromboembolic Disorder Trial Commences Subject Dosing by Sirius Sirius Pharmaceuticals, a leading biopharmaceutical company, has announced the commencement...
Bunions are a common foot condition that can cause pain and discomfort. They occur when the joint at the base...
The EkoSonic™ Endovascular System is a groundbreaking medical device that has revolutionized the treatment of peripheral arterial disease (PAD). This...
Immunotherapy Drug Makes Groundbreaking Progress in First Trial in Fifty Years In a significant breakthrough for cancer treatment, a new...
The California Institute for Regenerative Medicine (CIRM) has recently announced the allocation of $26 million towards clinical-stage research, with a...
An Overview of Genentech’s i-shaped Abs: A Bispecific Dendritic-T Cell Engager and Beyond Genentech, a leading biotechnology company, has been...
